RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy

Purpose: The lack of biomarkers that can distinguish aggressive from indolent prostate cancer has caused substantial overtreatment of clinically insignificant disease. Here, by genome-wide DNA methylome profiling, we sought to identify new biomarkers to improve the accuracy of prostate cancer diagno...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Strand, Siri H., Switnicki, Michal, Moller, Mia, Haldrup, Christa, Storebjerg, Tine M., Hedegaard, Jakob, Nordentoft, Iver, Hoyer, Soren, Borre, Michael, Pedersen, Jakob S., Wild, Peter J., Park, Jong Y., Orntoft, Torben F., Sorensen, Karina D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2016
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5351588/
https://ncbi.nlm.nih.gov/pubmed/28052017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14391
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg